Arranta Bio’s Boxborough Facility, Massachusetts

URLhttps://www.pharmaceutical-technology.com/projects
SourcePharmaceutical Technology
Date Published03/11/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Arranta Bio
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Reshoring
Total number of jobs (added or to be added):500
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2022
Domestically, the work will be done:In-house
Capital investment ($):150
City reshored to:Boxborough
State(s) reshored to:MA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredbiotherapeutic products, microbiome products
What domestic positive factors made reshoring more attractive?Impact on domestic economy, Skilled workforce availability/training
Find Reshoring Articles